Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers for irAEs in ICPI-Treated Cancer Patients
NCT05813418Recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Jul 2021
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHU Amiens-Picardie. Primary endpoints: Variation from baseline of IL6 concentration in irAEs patients at 6 months, Variation from baseline of IL10 concentration in irAEs patients at 6 months and 8 more. Started Jul 2021; status: recruiting.
Beyond the preview
Go deeper on NCT05813418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05813418.